News
The 5 Biggest Myths About Gold
Image source: Getty ImagesGold was once a common form of payment around the developed world, but after World War II the precious metal's influence began to wane. In 1971, when the United States....
3 Growth Stocks for Forward-Looking Investors
None of us has a crystal ball, but when it comes to investing success, one of the most important -- and often most difficult -- things to do is to identify companies that have a clear path of....
GROUPE LDLC : Convention franchises : LDLC.com fédère son réseau !
Les 6 et 7 novembre 2017 s'est tenue la 3ème convention nationale du réseau de magasins LDLC.com. Réunie dans le nouveau siège social du Groupe LDLC près de Lyon, une cinquantaine de....
Lucibel rend l'éclairage artificiel plus naturel
Quelques jours après l'annonce du Prix Nobel de médecine décerné à trois chercheurs américains pour leurs travaux sur l'horloge biologique, Lucibel met sur le marché Cronos. Ce luminaire....
FUTUREN starts construction works for a new wind farm and publishes its revenue for the first nine months of 2017
Consolidated revenue down by 2%, due to the decline in the Development and management of wind farms activity
Sales of electricity revenue up by + 5%
Ongoing construction works of....
FUTUREN ouvre un nouveau chantier de construction et publie son chiffre d'affaires pour les neuf premiers mois de 2017
Chiffre d'affaires consolidé en retrait de 2 %, dû au recul de l'activité développement et gestion de parcs
Chiffre d'affaires de Vente d'électricité en hausse de + 5 %
Construction en....
How Intel Corp. Stock Rose 20% in October
Microchip giant Intel (NASDAQ: INTC) was having a nice October. Share prices gained 8.6% in the first four weeks, leading up to the third-quarter earnings release. After crushing that report, the....
Is This Qualcomm’s Next Big Opportunity?
Qualcomm (NASDAQ: QCOM) is desperately in the hunt for new opportunities to overcome the body blow dealt by Apple's lawsuit and competition from MediaTek in smartphone chips. Not surprisingly, the....
Toyota Boosts Guidance as Profit Jumps 10%
Toyota Motor Corporation (NYSE: TM) said on Nov. 7 that its operating profit jumped 10% from a year ago in the quarter that ended on September 30, as a weaker yen boosted the Japanese auto giant's....
4 Top Airline Stocks to Buy Now
Over the past decade, consolidation has transformed the U.S. airline industry. The four largest airlines now control more than 80% of the market. However, competition is still fierce. American....
Ford: We'll Build Electric Cars in China Soon
It's official: Ford Motor Company (NYSE: F) has entered into a new joint venture that will build electric vehicles in -- and for -- China.It's the latest move in Ford CEO Jim Hackett's effort to....
4 Things to Know About New IPO MongoDB
One of the newest IPOs to hit the market is open-sourced database software company MongoDB (NASDAQ: MDB), which went public Oct. 19 at $24 per share and subsequently spiked 34%, before settling....
Here's What You Need to Know About Salesforce's Einstein
This week Salesforce (NYSE: CRM) is holding its 15th annual Dreamforce conference in San Francisco -- and expectations are high for its prized AI machine, Einstein. The event organizers are....
Starbucks and Unilever Strike a $384 Million Deal
Some people are willing to pay a fancy price for their favorite cup of tea. Global consumer-goods conglomerate Unilever (NYSE: UL) is taking that to an extreme: Last week it agreed to plonk down....
Here's How Apple Inc.'s iPhone Business Did in Fiscal 2017
Apple's (NASDAQ: AAPL) most recent quarter marked the end of a reasonably successful year for the company . Net revenue grew to $229.2 billion, up from $215.6 billion in the year prior, thanks to....
Twilio Inc. Smashed Q3 Sales Targets With 41% Growth
Communications software specialist Twilio (NYSE: TWLO) reported third-quarter results the evening of Nov. 8. The company's user base and revenues continued to skyrocket while the bottom line sank....
This Gene Therapy Can Restore Vision, but Will It Break the Bank?
In October, Spark Therapeutics (NASDAQ: ONCE) took another step closer to FDA approval for its vision-restoring drug, Luxturna. An approval for the gene-editing therapy early next year would be a....
Applied Optoelectronics Pleases Investors After Setting the Stage With Lowered Guidance
Shares of Applied Optoelectronics (NASDAQ: AAOI) started sinking after the company issued a preliminary third-quarter report on Oct. 12. Final results reported on Nov. 7 are sending the stock up....
Why Nordstrom, Inc. Stock Lost 16% in October
Shares of Nordstrom, Inc. (NYSE: JWN) were slumping last month alongside much of the retail industry, however, there was more than just the usual fears pushing the stock down. The founding....
Globus Medical Inc. Posts Solid 3rd-Quarter Results With Robots in Its Future
Globus Medical Inc. (NYSE: GMED) shareholders had to love the first half of 2017. The musculoskeletal-solutions company saw its stock price soar more than 30% by late June. Since then, Globus....
Hortonworks Lands the 2020 Census: What It Means for Investors
Hortonworks (NASDAQ: HDP) is an interesting company for growth investors, as it is very small but nevertheless works with very big enterprises and even bigger amounts of data. The company is one....
5 Things You Don't Want to Overlook in MannKind Corporation's Q3 Update
When a company reports a big loss that's worse than what analysts expected, you expect the stock to go down. That's exactly what happened with MannKind Corporation (NASDAQ: MNKD). After the market....
Darling Ingredients Diversifies Its Way to a Mixed Quarter
Darling Ingredients (NYSE: DAR) announced mixed third-quarter 2017 results on Nov. 8 after the market closed. The rendering and biodiesel specialist, whose shares are up 27% this year,....
Secoo Expects Tenfold Earnings Growth in Q3
Secoo (NASDAQ: SECO) recently announced preliminary third-quarter revenue and earnings estimates, and the numbers were stunning. The Chinese luxury e-tailer expects to generate $145.8 million to....
Here's What Overshadowed Valeant Pharmaceuticals in October, Pushing Its Shares Down 18%
Shares of Valeant Pharmaceuticals (NYSE: VRX), an embattled drug developer that's primarily grown through price hikes and acquisitions over the years, tumbled 18% during October, according to data....